KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $110,000 | -9.1% | 32,231 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $121,000 | -8.3% | 32,231 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $132,000 | -12.0% | 32,231 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $150,000 | -34.5% | 32,231 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $229,000 | -1.7% | 32,231 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $233,000 | +17.1% | 32,231 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $199,000 | +5.3% | 32,231 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $189,000 | +10.5% | 32,231 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $171,000 | -19.7% | 32,231 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $213,000 | +41.1% | 32,231 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $151,000 | +98.7% | 32,231 | +114.0% | 0.00% | 0.0% |
| Q4 2015 | $76,000 | +43.4% | 15,064 | 0.0% | 0.00% | – |
| Q3 2015 | $53,000 | -64.7% | 15,064 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $150,000 | – | 15,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |